(Total Views: 331)
Posted On: 12/13/2020 11:05:50 PM
Post# of 653
$RLFTF (copy) DD by allheartrader - If your a true investor here and have done your DD you should know that ARDS cases surpass 3 million a year (Prior to COVID-19) with a mortality rate of 50% to 90%.
Up until RLF-100 was introduced NOTHING has shown such promising results towards an effective treatment for this indication and that's not even to mention lesser Acute Lung Injury (ALI) or (NALI) numbers.
COVID-19 or not, this therapeutic, RLF-100 (Aviptadil) will have an unparalleled impact in future treatments for ALI, ARDS and other related lung injury indications including critical (at minimum-possibly mild thru critical) COVID-19 patients.
Have a nice evening,
Allheart
Up until RLF-100 was introduced NOTHING has shown such promising results towards an effective treatment for this indication and that's not even to mention lesser Acute Lung Injury (ALI) or (NALI) numbers.
COVID-19 or not, this therapeutic, RLF-100 (Aviptadil) will have an unparalleled impact in future treatments for ALI, ARDS and other related lung injury indications including critical (at minimum-possibly mild thru critical) COVID-19 patients.
Have a nice evening,
Allheart
(0)
(0)
$MJ
